---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-278392"
form_type: "8-K"
ticker: "ELDN"
cik: "0001404281"
company_name: "Eledon Pharmaceuticals, Inc."
filed_at: "2025-11-13T23:59:59+00:00"
generated_at: "2026-05-16T20:14:15.811559+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Eledon raises ~$46.5M in public offering of common stock and pre-funded warrants

## Summary
- Underwritten offering of 15.15M shares at $1.65/share and up to 15.15M pre-funded warrants at $1.649/warrant.
- Net proceeds estimated at $46.5M; up to $53.6M if underwriters' 30-day option is fully exercised.
- Proceeds to fund clinical development of product candidates and for general corporate purposes.
- Underwriters granted 30-day option to purchase up to 4.55M additional shares of common stock.
- Company and certain insiders subject to 60-day lock-up on sales of securities.

## SEC filing metadata
- accession: 0001193125-25-278392
- form_type: 8-K
- ticker: ELDN
- cik: 0001404281
- company_name: Eledon Pharmaceuticals, Inc.
- filed_at: 2025-11-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1404281/000119312525278392/0001193125-25-278392-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1404281/000119312525278392/d28785d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-278392
- JSON: https://secwatch.observer/filing/0001193125-25-278392.json
- Plain text: https://secwatch.observer/filing/0001193125-25-278392.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.